POST Online Media Lite Edition


Incyte Corporation: Wendy Dixon new director

Staff writer |
Wilmington, De., USA - May 26, 2010, Wilmington, De., USA - Incyte Corporation announced that Wendy Dixon has joined the company's board of directors.

Ms. Dixon, Ph.D., is former Chief Marketing Officer and President, Global Marketing at Bristol-Myers Squibb Company (BMS). Dr. Dixon’s qualifications and prior experience include 30 years in the biopharmaceutical industry involving multiple product launches and new drug approvals across a broad range of therapeutic areas.

In addition to her prior role at BMS, Dr. Dixon has held senior management, marketing, business development and regulatory affairs positions at Merck, Osteotech, Centocor and SmithKline & French (now a part of GlaxoSmithKline).


What to read next

Rockhopper finance director to leave
bluebird bio adds two to its board of directors
Ventus appoints Jo Dixon as director